Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
In vivo studies of adenovirus-based p53 gene therapy for ovarian cancer
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'In vivo studies of adenovirus-based p53 gene therapy for ovarian cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ovarian Cancer
100%
Adenovirus
100%
P53 Gene Therapy
100%
Dosing Regimen
28%
Nude Mice
28%
Cancer Therapy
14%
Tumor Cells
14%
Adverse Effects
14%
Clinical Application
14%
Treatment Response
14%
Treatment Schedule
14%
Biologically Active
14%
One-group
14%
Intraperitoneal Injection
14%
Administration Regimen
14%
Wild-type p53
14%
TP53 mutation
14%
Survival Time
14%
Gene Therapy
14%
Cancer Gene Therapy
14%
Safety Efficacy
14%
Survival Benefit
14%
Nude Mouse Model
14%
Activity-dependent Gene Expression
14%
Survival Duration
14%
Safety Toxicity
14%
Increasing Dose
14%
Tumor Growth Inhibition
14%
Human Ovarian Cancer Cells
14%
Biochemistry, Genetics and Molecular Biology
P53
100%
Protein P53
100%
Adenoviridae
100%
In Vivo Study
100%
Gene Therapy
100%
Nude Mouse
27%
Galactose
18%
Cancer Cell
9%
Growth Inhibition
9%
Mouse Model
9%
Wild Type
9%
Tumor Progression
9%
Drug Dose Regimen
9%
Survival Time
9%
Tumor Gene
9%
Gene Therapy
9%
Medicine and Dentistry
Adenoviridae
100%
Gene Therapy
100%
Ovarian Cancer
100%
Protein P53
100%
Galactose
16%
Phenformin
16%
Adverse Event
8%
Treatment Response
8%
Drug Dose Regimen
8%
Intraperitoneal Drug Administration
8%
Tumor Cell
8%
Cancer Therapy
8%
Survival Time
8%
Ovarian Cancer Cell Line
8%
Cancer Inhibition
8%
Tumor Gene
8%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Ovary Cancer
100%
Adenoviridae
100%
Nude Mouse
25%
Galactose
16%
Phenformin
16%
Adverse Event
8%
Mouse Model
8%
Malignant Neoplasm
8%
Neoplasm
8%
Intraperitoneal Injection
8%
Cancer Inhibition
8%
Survival Time
8%
Immunology and Microbiology
P53
100%
Adenoviridae
100%
Protein P53
100%
Nude Mouse
27%
Mouse Model
9%
Wild Type
9%
Drug Dose Regimen
9%
Tumor Cell
9%
Growth Inhibition
9%
Ovarian Cancer Cell Line
9%
Survival Time
9%
Tumor Gene
9%